This was originally sent to the people on the Floxie Hope Email List. If you would like posts like this sent to you, please sign up for the list HERE. Thank you! 

I found this article to be really interesting, and wanted to share it with you. It was published on, and is entitled, “Levofloxacin and Risk of Seizures.”

Levofloxacin is a fluoroquinolone antibiotic that is used to treat bacterial infections of the skin, sinuses, kidneys, bladder, or prostate. Fluoroquinolone antibiotics can cause serious or disabling side effects that may not be reversible. Taking levofloxacin may affect the brain or nervous system and cause seizures, epilepsy, stroke, changed brain structure, or kidney disease.

Awareness of personalised therapeutics for levofloxacin seems to be poor in clinical practice, and is reflected in prescribing patterns. Pharmacokinetic pharmacodynamic studies have raised concerns about suboptimal patient outcomes with the use of levofloxacin for some Gram-negative infections.1

A study on the pharmacogenetics of levofloxacin showed indirect evidence suggesting a temporal relationship between intravenous levofloxacin and new onset seizures. A patient in the study carried one variant allele for all three SNPs in ABCB1 gene. The study suggests that the seizures observed shortly after levofloxacin infusion were related to higher than expected penetration of the drug through the brain due to a genetically determined impaired activity of efflux proteins highly expressed in the blood-brain barrier. 2

ABCB1 gene is partly responsible for encoding a drug transporter in the blood-brain barrier. 3″

Perhaps other fluoroquinolone toxicity symptoms, not just seizures, are also related to variant alleles in SNPs in ABCB1 genes. I would love to see more research or articles on the topic. If you have any good articles about genetic variants that may be related to fluoroquinolone toxicity reactions, please don’t hesitate to send them to me. I’d love to see them.
Thanks, and I hope that you are all doing as well as possible.